hydroxychloroquine has been researched along with Immunologic Deficiency Syndromes in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hydroxychloroquine therapy induced simultaneous resolution of lupus and angioedema." | 3.68 | Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. ( Bagot, M; Intrator, L; Ochonisky, S; Revuz, J; Wechsler, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campochiaro, C | 1 |
| Atay, S | 1 |
| Clark, KEN | 1 |
| Ong, V | 1 |
| Denton, CP | 1 |
| Li, GM | 1 |
| Liu, HM | 1 |
| Guan, WZ | 1 |
| Xu, H | 1 |
| Wu, BB | 1 |
| Feng, JY | 1 |
| Sun, L | 1 |
| Jachiet, M | 1 |
| Flageul, B | 1 |
| Deroux, A | 1 |
| Le Quellec, A | 1 |
| Maurier, F | 1 |
| Cordoliani, F | 1 |
| Godmer, P | 1 |
| Abasq, C | 1 |
| Astudillo, L | 1 |
| Belenotti, P | 1 |
| Bessis, D | 1 |
| Bigot, A | 1 |
| Doutre, MS | 1 |
| Ebbo, M | 1 |
| Guichard, I | 1 |
| Hachulla, E | 1 |
| Héron, E | 1 |
| Jeudy, G | 1 |
| Jourde-Chiche, N | 1 |
| Jullien, D | 1 |
| Lavigne, C | 1 |
| Machet, L | 1 |
| Macher, MA | 1 |
| Martel, C | 1 |
| Melboucy-Belkhir, S | 1 |
| Morice, C | 1 |
| Petit, A | 1 |
| Simorre, B | 1 |
| Zenone, T | 1 |
| Bouillet, L | 1 |
| Bagot, M | 2 |
| Frémeaux-Bacchi, V | 1 |
| Guillevin, L | 1 |
| Mouthon, L | 1 |
| Dupin, N | 1 |
| Aractingi, S | 1 |
| Terrier, B | 1 |
| Ochonisky, S | 1 |
| Intrator, L | 1 |
| Wechsler, J | 1 |
| Revuz, J | 1 |
| Hauptmann, G | 1 |
| Grosshans, E | 1 |
| Heid, E | 1 |
| Mayer, S | 1 |
| Basset, A | 1 |
5 other studies available for hydroxychloroquine and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency.
Topics: Adult; Aftercare; Antirheumatic Agents; Autoimmune Diseases; Humans; Hydroxychloroquine; Iloprost; I | 2019 |
A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report.
Topics: Adolescent; Antibodies, Antinuclear; Asian People; Class I Phosphatidylinositol 3-Kinases; Complemen | 2019 |
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colchicine; Comorbidity; Complement C1q; Female; France; | 2015 |
Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus.
Topics: Angioedema; Complement C1 Inactivator Proteins; Female; Humans; Hydroxychloroquine; Immunologic Defi | 1993 |
[Acute lupus erythematosus with total absence of the C4 fraction of complement].
Topics: Adolescent; Complement System Proteins; Cortisone; Female; Fluorescent Antibody Technique; Humans; H | 1974 |